Telomerase: A potential molecular marker and therapeutic target for cancer

This publication has 13 references indexed in Scilit:

• Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the TRAIL Gene from the Human Telomerase Reverse Transcriptase Promoter
  Clinical Cancer Research, 2004
• Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus
  Journal of Surgical Oncology, 2004
• A Novel Conditionally Replicative Adenovirus Vector Targeting Telomerase-Positive Tumor Cells
  Clinical Cancer Research, 2004
• Characterisation of telomerase immortalised normal human oesophageal squamous cells
  Gut, 2003
• Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells
  Oncogene, 2002
• Clinical utility of telomerase in cancer
  Oncogene, 2002
• hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity
  Gene Therapy, 2002
• Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
  Nature Medicine, 2000
• A Novel Telomerase-Specific Gene Therapy: Gene Transfer of Caspase-8 Utilizing the Human Telomerase Catalytic Subunit Gene Promoter
  Human Gene Therapy, 2000
• Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
  Proceedings of the National Academy of Sciences, 1999